Proskauer on Class and Collective Actions
Subscribe to all posts by Joshua F. Alloy

Second Circuit Requires Specificity In FLSA Pleading

In Lundy v. Catholic Health System of Long Island Inc., Plaintiffs – a respiratory therapist and two nurses – sued on behalf of a putative class of similarly situated employees and alleged that the Catholic Health System of Long Island, Inc. (a collection of hospitals and healthcare providers) failed to compensate them for time worked … Continue Reading

Supreme Court Finds Pharmaceutical Sales Representatives Exempt From Overtime; Department of Labor’s Interpretation of FLSA Regulations Not Entitled To Any Deference

In a much-anticipated decision in Christopher v. SmithKline Beecham Corp., on June 18, 2012, the U.S. Supreme Court held 5-4 that pharmaceutical sales representatives are exempt from overtime under the Fair Labor Standard Act’s outside sales exemption because they “make sales” under the most reasonable interpretation of the law. In its holding, the Court unanimously … Continue Reading

Supreme Court Hears Oral Argument On Whether Pharmaceutical Sales Representatives Are Exempt From Overtime

Yesterday, in a packed courtroom, the United States Supreme Court heard oral argument in Christopher v. SmithKline Beecham Corp., No. 11-204 (on appeal from the Ninth Circuit) to determine whether the pharmaceutical industry has been properly classifying its sales representatives as “exempt” from overtime for the past 75 years under the Fair Labor Standards Act’s … Continue Reading

Third Circuit Signals End To “Hybrid” Class Action Debate

In February 2011, we previously posted about two decisions from Hon. John E. Jones III, of the Middle District of Pennsylvania, who ruled that FLSA collective actions are inherently incompatible with state law wage and hour claims when brought in the same action – i.e., so-called dual-filed or “hybrid” class actions. [Insert Link to February … Continue Reading